Department of Radiology

Publications

2023

Bhattarai A, Tanaka R, Yeung AW, Vardhanabhuti V. Photon-Counting CT Material Decomposition in Bone Imaging. J Imaging. 2023;9(10).

Prigerson HG, Viola M, Maciejewski PK, Falzarano F. Advance care planning (ACP) to promote receipt of value-concordant care: Results vary according to patient priorities. PLoS One. 2023;18(1):e0280197.

Jett S, Dyke JP, Yepez CB, Zarate C, Carlton C, Schelbaum E, et al. Effects of sex and APOE ε4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy study. PLoS One. 2023;18(2):e0281302.

Hoerig C, Hoang QV, Aichele J, Catheline S, Mamou J. High-frequency ultrasound point-of-care device to quantify myopia-induced microstructural changes in the anterior sclera. Ophthalmic Physiol Opt. 2023;43(3):544-557.

Homssi M, Sweeney EM, Demmon E, Mannheim W, Sakirsky M, Wang Y, et al. Evaluation of the Statistical Detection of Change Algorithm for Screening Patients with MS with New Lesion Activity on Longitudinal Brain MRI. AJNR Am J Neuroradiol. 2023;44(6):649-655.

Kim SH, Chang SJ, Dobri G, Strauss S, Lin E, Zavaletta V, et al. [68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort. Pituitary. 2023;26(4):419-428.

Bilgic B, Costagli M, Chan K-, Duyn J, Langkammer C, Lee J, et al. Recommended Implementation of Quantitative Susceptibility Mapping for Clinical Research in The Brain: A Consensus of the ISMRM Electro-Magnetic Tissue Properties Study Group. ArXiv. 2023.

Zhou G, Chen Y, Chien C, Revatta L, Ferdous J, Chen M, et al. Deep learning analysis of blood flow sounds to detect arteriovenous fistula stenosis. NPJ Digit Med. 2023;6(1):163.

Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023;50(5):1466-1486.

Karbhari A, Mosessian S, Trivedi KH, Valla F, Jacobson M, Truty MJ, et al. Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol. PLoS One. 2023;18(11):e0294564.